Emerging Diseases News

Patients diagnosed with COVID-19 during the first 3 months of the pandemic had a twofold higher risk for developing alcohol use disorder, likely driven by anxiety and fear surrounding the pandemic, according to new research.

Outpatient antibiotic prescribing fell more than 25% in 2020 compared with earlier years across all ages, but researchers found most of the prescribing was among adults, according to a study published in Open Forum Infectious Diseases.

Patients with systemic lupus erythematosus who are vaccinated for COVID-19 demonstrate reduced antibody levels compared with vaccinated controls, according to data published in Arthritis Care & Research.

An analysis of COVID-19 outcomes among people being treated for HIV or taking PrEP for HIV prevention found that the HIV medication tenofovir was associated with a lower rate of clinical events, suggesting a protective effect.

Around one-quarter of surveyed parents reported not adhering to a public health measures against COVID-19.

In the early months of 2020, amid a rapidly worsening pandemic, the U.S. government declared public health and national emergencies to help the country respond to COVID-19.

Vaccination against COVID-19 is strongly recommended in patients with celiac disease, who are at greater risk for hospitalization due to SARS-CoV-2 infection compared with people who do not have celiac disease, according to research.

A longer interval between doses of COVID-19 vaccine in children aged 5 to 11 years was associated with higher effectiveness against symptomatic infection, according to a real-world study published in Pediatrics.

SCOTTSDALE, Ariz. — In the absence of approved long COVID therapies, rheumatologists are encouraged to treat the symptoms and “listen empathically,” noted a presenter at the Basic and Clinical Immunology for the Busy Clinician symposium.

NEW ORLEANS — A therapeutic vs. prophylactic dose of anticoagulation therapy did not significantly improve outcomes for noncritically ill patients hospitalized with COVID-19, though fewer therapeutic dose-treated patients died at 30 days.